Brown: Risk Weighti...
Health Care: Drugs
Dynavax Technologies Corporation (DVAX: NASDAQ)
$2.51 0.02 | 0.80%
05/17/13 - 04:00 PM ET
Latest Dividend:0.00
Latest Dividend Yield:0.00%
Dividend Ex-Date:12/31/69
Price Earnings Ratio:n/a
Price Earnings Comparisons:
| DVAX | Sector Avg. | S&P 500 |
|---|---|---|
| n/a | 0.00 | 17.70 |
Price Performance History (% change):
| 3 Mo | 1 Yr | 3 Yr |
|---|---|---|
| -20.95 | -34.12 | 30.37 |
| GROWTH | 12 Mo | 3 Yr | CAGR |
|---|---|---|---|
| Revenue | -55.10 | -0.76 | -0.37 |
| Net Income | 1.29 | 0.00 | |
| EPS | -0.46 | 0.00 |
Earnings for DVAX:
| EBITDA | -67.00 |
| REVENUE | 9.71M |
Average Earnings Estimates
| Qtr (06/13) | Qtr (09/13) | FY (12/13) | FY (12/14) | |
|---|---|---|---|---|
| Average Estimate | $-0.10 | $-0.11 | $-0.44 | $-0.43 |
| Number of Analysts | 3 | 3 | 3 | 3 |
| High Estimate | $-0.07 | $-0.10 | $-0.41 | $-0.36 |
| Low Estimate | $-0.12 | $-0.13 | $-0.49 | $-0.48 |
| Prior Year | $-0.09 | $-0.10 | $-0.41 | $-0.44 |
| Growth Rate (Year over Year) | -11.11% | -13.33% | -6.50% | 0.76% |
Portfolios with DVAX
- Portfolio NameUser Type
- ContributorStocks Under-$10 Moving Hig...
- Usercdm1
- ContributorBreakout Stocks Of The Week...
- ContributorStocks Under-$10 Setting Up...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
- ContributorDrugs Facing FDA Approval i...
- Contributor10 Stocks Boosting Little F...
- ContributorStocks Under-$10 Moving Hig...
- Contributor10 Stocks of Top-Performing...
Latest DVAX Headlines from TheStreet
- 5 Stocks Under $5 to Watch 03.13.13 | 07:03 am
- Stocks Waver as Investors Eye Italian Election 02.25.13 | 02:02 pm
- Dynavax May Seek Quick Re-File of HepB Vax Following FDA Rejection 02.25.13 | 07:02 am
- Stock Futures Point to Higher Open 02.25.13 | 07:02 am
- Run-Up Trade Into Dynavax's FDA Approval Decision 02.13.13 | 07:02 am
- Dynavax Options Trade For Heplisav FDA Approval Decision 02.12.13 | 08:02 am
- Biotech Stock Mailbag: Dynavax, ImmunoCellular, Celldex and Medgenics 02.08.13 | 06:02 am
- 5 Stocks Under $10 Ready to Soar Higher 02.07.13 | 01:02 pm
- 'Mad Money' Lightning Round: I'm Avoiding Controversial Coinstar 02.07.13 | 06:02 am
- Cramer's 'Mad Money' Recap: Pay Attention 02.06.13 | 07:02 pm
Press Releases for DVAX
Partner Headlines for DVAX
- Why Dynavax's HEPLISAV Is Likely To Be Approved: Impact On Future Vaccine Development - Seeking Alpha 11.21.12 | 09:11 am
- Mid-Day Markets Update: Markets Recover on Fiscal Cliff Meeting; Casino Stocks Continue to Ramp - Benzinga 11.16.12 | 01:11 pm
- Dynavax Gets Crushed After Advisory Committee Vote - Seeking Alpha 11.16.12 | 09:11 am
- Cramer's Mad Money - 10 Things To Watch In The Week Ahead (9/14/12) - Seeking Alpha 09.16.12 | 06:09 am
- 3 Vaccine Companies With Upcoming Catalysts - Seeking Alpha 09.09.12 | 08:09 am
- Company News for May 10, 2012 - Corporate Summary - Zacks 05.10.12 | 10:05 am
- Buy And Sell Ideas Based On Monday's Big Biotech News Movers - Seeking Alpha 10.11.11 | 08:10 am
- Dynavax Reports Diabetic Subset Data From Modified Intent to Treat Analysis of the HEPLISAV Phase 3 Trial - Benzinga 10.06.11 | 04:10 pm
- 7 Breakout Stocks With Sufficient Cash to Cover Operating Expenses - Seeking Alpha 03.29.11 | 08:03 am
- Data from Dynavax for HBV Candidate - Analyst Blog - Zacks 12.27.10 | 01:12 pm
